The binding of mAb CC4 to bladder cancer T2-4 cells transfected with CEACAM5-expressing vectors further validated the recognition of mAb CC4 to CEACAM5 (Figure 1G). Here, CEACAM5 is linked to urinary bladder carcinoma.